Modifies provisions relating to health care
HB 943 is a broad health care omnibus bill that repeals and reenacts numerous Missouri statutes affecting hospitals, ambulance districts, emergency medical services, pharmacy practice, MO HealthNet, dental practice, disability placards, and related public health rules. The bill updates or expands authority for hospital and hospital-district investment practices, revises rules for hospital and ambulance service licensing and governance, and adds or clarifies training, audit, disclosure, and certification requirements for ambulance district board members, ambulance service administrators, and community paramedic programs.
The bill also makes a wide range of targeted health policy changes. It expands expedited partner therapy to additional sexually transmitted infections and to a broader class of health care professionals; requires epinephrine auto-injectors on basic life support ambulances and stretcher vans; updates pharmacy authority to administer vaccines and operate medication therapy protocols; creates the RX Cares for Missouri Program to support medication safety and reduce prescription drug abuse; and revises MO HealthNet coverage and reimbursement provisions, including adding specific exclusions for gender transition procedures and related drugs. It also changes rules for patient record access, ambulance service insolvency procedures, referral agency disclosures for long-term care placements, and dental services provided through hospitals, nonprofits, and federally qualified health centers.
In terms of state law impact, the bill would repeal and replace a large number of existing sections in the Revised Statutes of Missouri and create new sections governing health care operations and oversight. It raises or adjusts several thresholds and standards, such as hospital investment limits, tax-revenue eligibility tests, pseudoephedrine purchase limits, and the scope of entities that may stock and administer epinephrine. It also strengthens public transparency and compliance requirements through public audits, website disclosure, training mandates, and expanded reporting and enforcement powers for state agencies.
The overall sentiment reflected in the vote was strongly favorable. The bill advanced on the House third-reading calendar by a wide margin, 125 yeas to 30 nays, indicating broad support for the package despite its size and the number of policy changes it contains. No committee transcript was provided, so the available record shows support in the House but does not capture detailed floor debate or committee concerns.
The main points of contention appear to be the bill’s more controversial policy riders and regulatory changes rather than the general health care modernization theme. Likely areas of dispute include the MO HealthNet exclusion for gender transition surgeries, cross-sex hormones, and puberty blockers; the tighter controls and enforcement around pseudoephedrine and methamphetamine precursor drugs; and the expanded state oversight of ambulance and hospital operations. Other potentially sensitive changes include the new training/disqualification rules for ambulance district board members and the broader restructuring of health care provider and facility authority.
HB 943 would substantially revise Missouri law across multiple health care-related chapters by repealing and reenacting provisions governing hospitals, ambulance districts, emergency medical services, pharmacy, public health testing, MO HealthNet, dental practice, disability placards, and controlled-substance precursor sales. It would expand or clarify the authority of hospitals, ambulance services, pharmacists, and certain health care entities while adding new training, certification, disclosure, audit, and reporting requirements for regulated parties and state agencies. The bill also changes reimbursement and coverage rules in MO HealthNet and updates criminal penalties and enforcement provisions tied to pseudoephedrine and related products.
The bill appears to have been received positively overall in the House, as shown by the 125-30 third-reading vote. That margin suggests broad bipartisan or at least cross-faction support for the bill’s general health care and emergency-services reforms. At the same time, the breadth of the bill and the inclusion of several policy-specific changes likely generated some opposition, especially on the more contentious coverage and regulatory provisions.
The most notable points of contention are likely the bill’s policy riders that go beyond administrative health care updates. The MO HealthNet provision barring payments for gender transition surgeries, cross-sex hormones, and puberty-blocking drugs is likely to be the most divisive section. Additional likely flashpoints include the stricter pseudoephedrine limits and enforcement provisions, the expanded state control over ambulance district governance and training, and the new requirements affecting hospital and ambulance licensing, which could be viewed as either accountability measures or burdensome regulation depending on the stakeholder.